Burning Rock offers integrated central lab services for biopharma partners, from multimodal sample testing to data analysis, meeting drug developing requirement, with four industry-leading qualifications (CLIA, CAP, NCCL, and NMPA) and full spectra of diagnostic products. So far, we have provided central lab services with >50 clinical research studies for >30 pharmaceutical companies, covering clinical study sites globally.
Biomarker discovery
Inclusion/exclusion screening
Patient stratification
Registered clinical studies
Investigator-initiated studies
Real world studies